Accurate measurement of nicotinamide adenine dinucleotide (NAD+) with high-performance liquid chromatography

Methods in Molecular Biology

Volumn 1077, Issue , 2013, Pages 203-215

  Yoshino, Jun ^a   Imai, Shin Ichiro ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HPLC; NAMPT; Nicotinamide adenine dinucleotide (NAD+)

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; CELL CULTURE; DEGRADATION; FREEZE THAWING; LIQUID CHROMATOGRAPHY; MEASUREMENT ACCURACY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; TISSUES;

ANIMALS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; HUMANS; MICE; NAD; NIH 3T3 CELLS; TANDEM MASS SPECTROMETRY;

EID: 84884187386     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-637-5_14     Document Type: Article

References (31)

1. Belenky P, Bogan KL, Brenner C (2007) NAD + metabolism in health and disease. Trends Biochem Sci 32(1):12-19. doi: 10.1016/j.tibs.2006.11.006
2. Stein LR, Imai S (2012) The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab 23(9):420-428. doi: 10.1016/j.tem.2012.06. 005
3. Revollo JR, Grimm AA, Imai S (2007) The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 23(2):164-170. doi: 10.1097/MOG.0b013e32801b3c8f
4. Imai S (2009) The NAD world: a new systemic regulatory network for metabolism and aging-Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 53(2):65-74. doi: 10.1007/s12013-008-9041-4
5. Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S (1999) Enzymology of NAD + synthesis. Adv Enzymol Relat Areas Mol Biol 73:135-182
6. Bogan KL, Brenner C (2008) Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD + precursor vitamins in human nutrition. Annu Rev Nutr 28:115-130. doi: 10.1146/annurev. nutr.28.061807.155443
7. Revollo JR, Grimm AA, Imai S (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279(49):50754-50763. doi: 10.1074/jbc. M408388200
8. Krishnakumar R, Kraus WL (2010) The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 39(1):8-24. doi: 10.1016/j. molcel.2010.06.017
9. Bai P, Canto C (2012) The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab 16(3):290-295. doi: 10.1016/j.cmet.2012.06. 016
10. Corda D, Di Girolamo M (2003) Functional aspects of protein mono-ADP-ribosylation. EMBO J 22(9):1953-1958. doi: 10.1093/emboj/cdg209
11. Lee HC (2001) Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol 41:317-345. doi: 10.1146/annurev.pharmtox.41.1.317
12. Imai S, Guarente L (2010) Ten years of NAD dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 31(5):212-220. doi: 10.1016/j.tips.2010.02.003
13. Guarente L (2011) Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Eng J Med 364(23):2235-2244. doi: 10.1056/NEJMra1100831
14. Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C, Takahashi JS, Imai S, Bass J (2009) Circadian clock feedback cycle through NAMPT-mediated NAD + biosynthesis. Science 324(5927):651-654. doi: 10.1126/science.1171641
15. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P (2009) Circadian control of the NAD + salvage pathway by CLOCKSIRT1. Science 324(5927):654-657. doi: 10.1126/science.1170803
16. Imai S (2010) "Clocks" in the NAD world: NAD as a metabolic oscillator for the regulation of metabolism and aging. Biochim Biophys Acta 1804(8):1584-1590. doi: 10.1016/j.bbapap.2009.10.024
17. Yoshino J, Mills KF, Yoon MJ, Imai S (2011) Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet-and age-induced diabetes in mice. Cell Metab 14(4):528-536. doi: 10.1016/j. cmet.2011.08.014
18. Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR, Milbrandt J, Kiess W, Imai S (2007) Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6(5):363-375. doi: 10.1016/j.cmet.2007.09.003
19. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461-468. doi: 10.1016/j.cmet.2011.03.004
20. Barbosa MT, Soares SM, Novak CM, Sinclair D, Levine JA, Aksoy P, Chini EN (2007) The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J 21(13):3629-3639. doi: 10.1096/fj.07-8290com
21. Gillum MP, Erion DM, Shulman GI (2010) Sirtuin-1 regulation of mammalian metabolism. Trends Mol Med. doi: 10.1016/j. molmed.2010.09.005
22. Braidy N, Jayasena T, Poljak A, Sachdev PS (2012) Sirtuins in cognitive ageing and Alzheimer's disease. Curr Opin Psychiatry 25(3):226-230. doi: 10.1097/YCO.0b013e32835112c1
23. Donmez G, Wang D, Cohen DE, Guarente L (2010) SIRT1 Suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142(2):320-332. doi: 10.1016/j. cell.2010.06.020
24. Cohen-Kfir E, Artsi H, Levin A, Abramowitz E, Bajayo A, Gurt I, Zhong L, D'Urso A, Toiber D, Mostoslavsky R, Dresner-Pollak R (2011) Sirt1 is a regulator of bone mass and a repressor of sost encoding for sclerostin, a bone formation inhibitor. Endocrinology 152(12):4514-4524. doi: 10.1210/en.2011-1128
25. Li Y, He X, Li Y, He J, Anderstam B, Andersson G, Lindgren U (2011) Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals. J Bone Miner Res 26(11):2656-2664. doi: 10.1002/jbmr.480
26. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, Haigis MC (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 19(3):416-428. doi: 10.1016/j.ccr.2011.02.014
27. Sebastian C, Zwaans BM, Silberman DM, Gymrek M, Goren A, Zhong L, Ram O, Truelove J, Guimaraes AR, Toiber D, Cosentino C, Greenson JK, Macdonald AI, McGlynn L, Maxwell F, Edwards J, Giacosa S, Guccione E, Weissleder R, Bernstein BE, Regev A, Shiels PG, Lombard DB, Mostoslavsky R (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151(6):1185-1199. doi: 10.1016/j.cell.2012.10.047
28. Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez-Marcos PJ, Yamamoto H, Andreux PA, Cettour-Rose P, Gademann K, Rinsch C, Schoonjans K, Sauve AA, Auwerx J (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat dietinduced obesity. Cell Metab 15(6):838-847. doi: 10.1016/j.cmet.2012.04.022
29. Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O'Neil L, White TA, Sinclair DA, Chini EN (2012) Flavonoid apigenin is an inhibitor of the NAD + ase CD38: implications for cellular NAD + metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. doi: 10.2337/db12-1139
30. Imai S (2010) A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol Res 62(1):42-47. doi: 10.1016/j.phrs.2010.01.006
31. Hasmann M, Schemainda I (2003) FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63(21): 7436-7442